The following is a summary of “Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for ...

The findings of Furtado and colleagues support the general impression that intra-articular glucocorticoids might have greater efficacy and fewer side effects than systemically administered ...

A new study found no significant benefit in adding low-dose oral glucocorticoids to immunosuppressive therapy for improving skin fibrosis in patients with early diffuse cutaneous systemic ...

38% of the participants had been hospitalized in the last year. Glucocorticoid replacement therapy among the respondents consisted primarily of hydrocortisone administered twice or thrice daily.

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.

A once-yearly infusion of zoledronate is safe and could be more effective than daily or weekly oral bisphosphonate therapy in the treatment of glucocorticoid-induced osteoporosis, according to new ...

A Japanese study finds avacopan effective in ANCA-associated vasculitis, with 90% achieving remission at 12 months. However, ...

Corticosteroid signaling by glucocorticoids is mediated through two distinct intracellular receptor subtypes referred as the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR ...

Therefore, chronic stress or long-term hormone therapy can deplete the cellular ... induced proteasomal degradation of the ...

Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe ...